Prashant Joshi - Publications

Affiliations: 
2018- NMIMS University 
Area:
Drug design and Medicinal Chemistry of natural Products
Website:
https://pharmacy-shirpur.nmims.edu/faculty-and-research/faculty/dr-prashant-joshi/

28 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Patel DV, Patel NR, Kanhed AM, Teli DM, Patel KB, Joshi PD, Patel SP, Gandhi PM, Chaudhary BN, Prajapati NK, Patel KV, Yadav MR. Novel carbazole-stilbene hybrids as multifunctional anti-Alzheimer agents. Bioorganic Chemistry. 101: 103977. PMID 32485470 DOI: 10.1016/j.bioorg.2020.103977  0.358
2018 Joshi P, Sonawane VR, Williams IS, McCann GJP, Gatchie L, Sharma R, Satti N, Chaudhuri B, Bharate SB. Identification of karanjin isolated from the Indian beech tree as a potent CYP1 enzyme inhibitor with cellular efficacy screening of a natural product repository. Medchemcomm. 9: 371-382. PMID 30108931 DOI: 10.1039/c7md00388a  0.765
2017 Horley NJ, Beresford KJM, Kaduskar S, Joshi P, McCann GJP, Ruparelia KC, Williams IS, Gatchie L, Sonawane VR, Bharate SB, Chaudhuri B. (E)-3-(3,4,5-Trimethoxyphenyl)-1-(pyridin-4-yl)prop-2-en-1-one, a heterocyclic chalcone is a potent and selective CYP1A1 inhibitor and cancer chemopreventive agent. Bioorganic & Medicinal Chemistry Letters. PMID 29138024 DOI: 10.1016/j.bmcl.2017.11.009  0.714
2017 Singh S, Kalia NP, Joshi P, Kumar A, Sharma PR, Kumar A, Bharate SB, Khan IA. Boeravinone B, A Novel Dual Inhibitor of NorA Bacterial Efflux Pump of Staphylococcus aureus and Human P-Glycoprotein, Reduces the Biofilm Formation and Intracellular Invasion of Bacteria. Frontiers in Microbiology. 8: 1868. PMID 29046665 DOI: 10.3389/fmicb.2017.01868  0.672
2017 Williams IS, Chib S, Nuthakki V, Gatchie L, Joshi P, Narkhede N, Vishwakarma RA, Bharate SB, Saran S, Chaudhuri B. Biotransformation of chrysin to baicalein: Selective C6-hydroxylation of 5,7-dihydroxyflavone using whole yeast cells stably expressing human CYP1A1 enzyme. Journal of Agricultural and Food Chemistry. PMID 28782952 DOI: 10.1021/Acs.Jafc.7B02690  0.793
2017 Williams IS, Joshi P, Gatchie L, Sharma M, Satti NK, Vishwakarma RA, Chaudhuri B, Bharate SB. Synthesis and biological evaluation of pyrrole-based chalcones as CYP1 enzyme inhibitors, for possible prevention of cancer and overcoming cisplatin resistance. Bioorganic & Medicinal Chemistry Letters. PMID 28711350 DOI: 10.1016/J.Bmcl.2017.07.010  0.79
2017 Joshi P, Vishwakarma RA, Bharate SB. Natural alkaloids as P-gp inhibitors for multidrug resistance reversal in cancer. European Journal of Medicinal Chemistry. 138: 273-292. PMID 28675836 DOI: 10.1016/J.Ejmech.2017.06.047  0.685
2017 Joshi P, McCann GJP, Sonawane V, Vishwakarma RA, Chaudhuri B, Bharate SB. Identification of Potent and Selective CYP1A1 Inhibitors via Combined Ligand and Structure Based Virtual Screening and their In-vitro Validation in Sacchrosomes and Live human cells. Journal of Chemical Information and Modeling. PMID 28489395 DOI: 10.1021/Acs.Jcim.7B00095  0.726
2017 Mohd Siddique MU, McCann GJ, Sonawane VR, Horley N, Gatchie L, Joshi P, Bharate SB, Jayaprakash V, Sinha BN, Chaudhuri B. Quinazoline derivatives as selective CYP1B1 inhibitors. European Journal of Medicinal Chemistry. 130: 320-327. PMID 28259840 DOI: 10.1016/j.ejmech.2017.02.032  0.736
2017 Horley NJ, Beresford KJ, Chawla T, McCann GJ, Ruparelia KC, Gatchie L, Sonawane VR, Williams IS, Tan HL, Joshi P, Bharate SS, Kumar V, Bharate SB, Chaudhuri B. Discovery and characterization of novel CYP1B1 inhibitors based on heterocyclic chalcones: Overcoming cisplatin resistance in CYP1B1-overexpressing lines. European Journal of Medicinal Chemistry. 129: 159-174. PMID 28222316 DOI: 10.1016/j.ejmech.2017.02.016  0.738
2016 Joshi P, Gupta M, Vishwakarma RA, Kumar A, Bharate SB. (Z)-2-(3-Chlorobenzylidene)-3,4-dihydro-N-(2-methoxyethyl)-3-oxo-2H-benzo[b][1,4]oxazine-6-carboxamide as GSK-3β inhibitor: Identification by virtual screening, and its validation in enzyme and cell-based assay. Chemical Biology & Drug Design. PMID 27896926 DOI: 10.1111/Cbdd.12913  0.659
2016 Mohd Siddique MU, McCann GJ, Sonawane V, Horley N, Williams IS, Joshi P, Bharate SB, Jayaprakash V, Sinha BN, Chaudhuri B. Biphenyl urea derivatives as selective CYP1B1 inhibitors. Organic & Biomolecular Chemistry. 14: 8931-8936. PMID 27714268 DOI: 10.1039/c6ob01506a  0.737
2016 Yadav RR, Guru SK, Joshi P, Mahajan G, Mintoo MJ, Kumar V, Bharate SS, Mondhe DM, Vishwakarma RA, Bhushan S, Bharate SB. 6-Aryl substituted 4-(4-cyanomethyl) phenylamino quinazolines as a new class of isoform-selective PI3K-alpha inhibitors. European Journal of Medicinal Chemistry. 122: 731-743. PMID 27479483 DOI: 10.1016/J.Ejmech.2016.07.006  0.791
2016 Kumar V, Guru SK, Jain SK, Joshi P, Gandhi SG, Bharate SB, Bhushan S, Bharate SS, Vishwakarma RA. A chromatography-free isolation of rohitukine from leaves of Dysoxylum binectariferum: Evaluation for in vitro cytotoxicity, Cdk inhibition and physicochemical properties. Bioorganic & Medicinal Chemistry Letters. PMID 27363938 DOI: 10.1016/J.Bmcl.2016.06.046  0.794
2015 Manda S, Sharma S, Wani A, Joshi P, Kumar V, Guru SK, Bharate SS, Bhushan S, Vishwakarma RA, Kumar A, Bharate SB. Discovery of a marine-derived bis-indole alkaloid fascaplysin, as a new class of potent P-glycoprotein inducer and establishment of its structure-activity relationship. European Journal of Medicinal Chemistry. 107: 1-11. PMID 26560048 DOI: 10.1016/J.Ejmech.2015.10.049  0.761
2015 Yadav RR, Sharma S, Joshi P, Wani A, Vishwakarma RA, Kumar A, Bharate SB. Meridianin derivatives as potent Dyrk1A inhibitors and neuroprotective agents. Bioorganic & Medicinal Chemistry Letters. 25: 2948-52. PMID 26048785 DOI: 10.1016/J.Bmcl.2015.05.034  0.802
2015 Mahale S, Bharate SB, Manda S, Joshi P, Jenkins PR, Vishwakarma RA, Chaudhuri B. Antitumour potential of BPT: a dual inhibitor of cdk4 and tubulin polymerization. Cell Death & Disease. 6: e1743. PMID 25950473 DOI: 10.1038/Cddis.2015.96  0.622
2015 Singh B, Kumar A, Joshi P, Guru SK, Kumar S, Wani ZA, Mahajan G, Hussain A, Qazi AK, Kumar A, Bharate SS, Gupta BD, Sharma PR, Hamid A, Saxena AK, et al. Colchicine derivatives with potent anticancer activity and reduced P-glycoprotein induction liability. Organic & Biomolecular Chemistry. 13: 5674-89. PMID 25895604 DOI: 10.1039/C5Ob00406C  0.749
2015 Bharate JB, Singh S, Wani A, Sharma S, Joshi P, Khan IA, Kumar A, Vishwakarma RA, Bharate SB. Discovery of 4-acetyl-3-(4-fluorophenyl)-1-(p-tolyl)-5-methylpyrrole as a dual inhibitor of human P-glycoprotein and Staphylococcus aureus Nor A efflux pump. Organic & Biomolecular Chemistry. 13: 5424-31. PMID 25865846 DOI: 10.1039/C5Ob00246J  0.723
2015 Mudududdla R, Guru SK, Wani A, Sharma S, Joshi P, Vishwakarma RA, Kumar A, Bhushan S, Bharate SB. 3-(Benzo[d][1,3]dioxol-5-ylamino)-N-(4-fluorophenyl)thiophene-2-carboxamide overcomes cancer chemoresistance via inhibition of angiogenesis and P-glycoprotein efflux pump activity. Organic & Biomolecular Chemistry. 13: 4296-309. PMID 25758415 DOI: 10.1039/C5Ob00233H  0.817
2014 Mahale S, Bharate SB, Manda S, Joshi P, Bharate SS, Jenkins PR, Vishwakarma RA, Chaudhuri B. Biphenyl-4-carboxylic acid [2-(1H-indol-3-yl)-ethyl]-methylamide (CA224), a nonplanar analogue of fascaplysin, inhibits Cdk4 and tubulin polymerization: evaluation of in vitro and in vivo anticancer activity. Journal of Medicinal Chemistry. 57: 9658-72. PMID 25368960 DOI: 10.1021/Jm5014743  0.766
2014 Jain SK, Singh S, Khajuria A, Guru SK, Joshi P, Meena S, Nadkarni JR, Singh A, Bharate SS, Bhushan S, Bharate SB, Vishwakarma RA. Pyrano-isochromanones as IL-6 inhibitors: synthesis, in vitro and in vivo antiarthritic activity. Journal of Medicinal Chemistry. 57: 7085-97. PMID 25111439 DOI: 10.1021/Jm500901E  0.787
2014 Joshi P, Singh S, Wani A, Sharma S, Jain SK, Singh B, Gupta BD, Satti NK, Koul S, Khan IA, Kumar A, Bharate SB, Vishwakarma RA. Osthol and curcumin as inhibitors of human Pgp and multidrug efflux pumps of Staphylococcus aureus: Reversing the resistance against frontline antibacterial drugs Medchemcomm. 5: 1540-1547. DOI: 10.1039/C4Md00196F  0.74
2014 Bahl A, Joshi P, Bharate SB, Chopra H. Pharmacophore modeling and 3D-QSAR studies of leucettines as potent Dyrk2 inhibitors Medicinal Chemistry Research. 23: 1925-1933. DOI: 10.1007/s00044-013-0767-1  0.53
2013 Singh B, Sidiq T, Joshi P, Jain SK, Lawaniya Y, Kichlu S, Khajuria A, Vishwakarma RA, Bharate SB. Anti-inflammatory and immunomodulatory flavones from Actinocarya tibetica Benth. Natural Product Research. 27: 2227-30. PMID 23768253 DOI: 10.1080/14786419.2013.805334  0.759
2013 Bahl A, Joshi P, Bharate S, Chopra H. Pharmacophore Based 3D-QSAR Modeling and Molecular Docking of Leucettines as Potent Dyrk1A Inhibitors Letters in Drug Design & Discovery. 10: 719-726. DOI: 10.2174/15701808113100890024  0.521
2012 Jain SK, Meena S, Singh B, Bharate JB, Joshi P, Singh VP, Vishwakarma RA, Bharate SB. KF/alumina catalyzed regioselective benzylation and benzoylation using solvent-free grind-stone chemistry Rsc Advances. 2: 8929. DOI: 10.1039/C2Ra21154H  0.667
2012 Bharate SB, Manda S, Joshi P, Singh B, Vishwakarma RA. Total synthesis and anti-cholinesterase activity of marine-derived bis-indole alkaloid fascaplysin Medchemcomm. 3: 1098. DOI: 10.1039/C2Md20076G  0.649
Show low-probability matches.